Jelena Kolic

发表

Hiperspektralni senzori i primjena u šumarstvu

M. Ančić, Renata Pernar, Fran Bono Cindrić, 2019 .

Beta-cell specific Insr deletion promotes insulin hypersecretion and improves glucose tolerance prior to global insulin resistance

James D. Johnson, P. MacDonald, C. Nislow, 2022, Nature Communications.

Beta-cell specific Insr deletion promotes insulin hypersecretion and improves glucose tolerance prior to global insulin resistance

James D. Johnson, P. MacDonald, C. Nislow, 2020, Nature communications.

Functional plasticity of the human infant β-cell exocytotic phenotype.

X. Dai, A. Spigelman, G. Korbutt, 2013, Endocrinology.

G protein-coupled receptor (GPR)40-dependent potentiation of insulin secretion in mouse islets is mediated by protein kinase D1

P. MacDonald, M. Prentki, E. Olson, 2012, Diabetologia.

Detecting mistletoe infestation on Silver fir using hyperspectral images

M. Bajic, R. Pernar, A. Seletković, 2014 .

Proteomic predictors of individualized nutrient-specific insulin secretion in health and disease

P. MacDonald, L. Foster, A. Gloyn, 2023, medRxiv.

Beta-hydroxybutyrate promotes basal insulin secretion while decreasing glucagon secretion in mouse and human islets

George P. Brownrigg, Jelena Kolic, Renata Moravcova, 2024, bioRxiv.

cAMP-independent effects of GLP-1 on β cells.

P. MacDonald, J. Kolic, Jelena Kolic, 2015, The Journal of clinical investigation.

Beta-cell specific insulin resistance promotes glucose-stimulated insulin hypersecretion

James D. Johnson, P. MacDonald, C. Nislow, 2020, bioRxiv.

TCF1 links GIPR signaling to the control of beta cell function and survival

C. Streutker, P. MacDonald, J. Wrana, 2015, Nature Medicine.

Differential Effects of Voclosporin and Tacrolimus on Insulin Secretion From Human Islets

James D. Johnson, D. Ure, E. Panzhinskiy, 2020, bioRxiv.

Tacrolimus, but not voclosporin, inhibits insulin secretion from human islets at a clinical trough dose

James D. Johnson, D. Ure, E. Panzhinskiy, 2020 .

Promises and pitfalls of beta cell–replacement therapies

James D. Johnson, J. Kolic, Jelena Kolic, 2021, Nature Metabolism.

Proteomic predictors of individualized nutrient-specific insulin secretion in health and disease

A. Gloyn, A. Spigelman, H. Cen, 2024, Cell metabolism.

Insulin Secretion Induced by Glucose-dependent Insulinotropic Polypeptide Requires Phosphatidylinositol 3-Kinase γ in Rodent and Human β-Cells*

P. MacDonald, A. Spigelman, J. E. Manning Fox, 2014, The Journal of Biological Chemistry.

Distinct and opposing roles for the phosphatidylinositol 3-OH kinase catalytic subunits p110α and p110β in the regulation of insulin secretion from rodent and human beta cells

P. MacDonald, C. Hajmrle, A. Spigelman, 2013, Diabetologia.

Insulin Granule Recruitment and Exocytosis Is Dependent on p110γ in Insulinoma and Human β-Cells

P. MacDonald, J. E. Manning Fox, M. Woo, 2009, Diabetes.

SUMOylation regulates Kv2.1 and modulates pancreatic β-cell excitability

P. MacDonald, X. Dai, S. Sipione, 2009, Journal of Cell Science.

Pharmacological or genetic inhibition of Scn9a protects beta-cells while reducing insulin secretion in type 1 diabetes

James D. Johnson, P. MacDonald, X. Dai, 2023, bioRxiv.

TCF 1 links GIPR signaling to the control of beta cell function and survival

C. Streutker, P. MacDonald, J. Wrana, 2015 .

cAMP-independent effects of GLP-1 on β cells.

P. MacDonald, Jelena Kolic, 2015, The Journal of clinical investigation.

PI3 kinases p110α and PI3K-C2β negatively regulate cAMP via PDE3/8 to control insulin secretion in mouse and human islets

P. MacDonald, M. Ferdaoussi, A. Spigelman, 2016, Molecular metabolism.